United Kingdom — National Health Service & Palantir

United Kingdom — National Health Service: The United Kingdom — National Health Service in the United Kingdom is reviewing its $441 million contract with Palantir, creating uncertainty for Palantir's international government business.

Palantir: Palantir is the central entity of this event, with its stock performance, financial results, and valuation being the primary focus of the articles. The company has experienced significant revenue growth, particularly in its U.S. commercial segment, driven by its Artificial Intelligence Platform (AIP).